73 related articles for article (PubMed ID: 5379889)
1. [Use of Xylamide (MILID) as an antisecretory-antigastrinic agent in acute pancreatitis].
Margnelli M; Zacco R; Velati GF
Minerva Gastroenterol; 1969; 15(4):229-34. PubMed ID: 5379889
[No Abstract] [Full Text] [Related]
2. [Study of gastric secretory function and its inhibition with Xylamide. The maximal acid output (MAO) test and the Hollander test].
Arias Vallejo E; Diaz G; Moreno Arranz B; Lozano L
Minerva Med; 1969 Mar; 60(23):1063-9. PubMed ID: 5781334
[No Abstract] [Full Text] [Related]
3. [Clinical study of a new anti-ulcer drug: CR-242, Xylamide, in 23 cases].
Uzeta Mejia S
Minerva Med; 1969 Mar; 60(23):1070-3. PubMed ID: 5781335
[No Abstract] [Full Text] [Related]
4. [Therapy of gastro-duodenal ulcer, gastritis and gastroduodenitis with an antisecretory, non-anticholinergic drug (Milid)].
Borellini D; Milvio C
Minerva Med; 1969 Mar; 60(23):1053-6. PubMed ID: 5781332
[No Abstract] [Full Text] [Related]
5. [Xylamide (Milid) therapy of gastroduodenitis in patients with saturnism].
Gambini G; Grisler R
Minerva Med; 1969 Mar; 60(23):1017-23. PubMed ID: 5781327
[No Abstract] [Full Text] [Related]
6. [Inhibiting effects of Xylamide on induced maximal gastric acid secretion in humans].
Sampietro R
Minerva Med; 1969 Mar; 60(23):1032-7. PubMed ID: 5781329
[No Abstract] [Full Text] [Related]
7. [Therapeutic activity in gastric and duodenal ulcers, gastritis and gastroduodenitis of an anti-secretory, non-anticholinergic drug].
Bianchi PG; Saccabusi E
Minerva Med; 1969 Mar; 60(23):1044-52. PubMed ID: 5781331
[No Abstract] [Full Text] [Related]
8. [Evaluation of the antigastrin effect of xilamide].
Laudano OM
Prensa Med Argent; 1968 Nov; 55(40):1896-8. PubMed ID: 5714058
[No Abstract] [Full Text] [Related]
9. [Pharmacological and clinical studies of a non-anticholinergic antisecretory product: Milid (xylamide, CR 242)].
Mainoli S; Milvio C; Borellini D
Minerva Med; 1967 Oct; 58(86):3708-12. PubMed ID: 6061066
[No Abstract] [Full Text] [Related]
10. [Clinical experiences with CR-242, Xylamide, in the treatment of gastroduodenal ulcerous disease. Study of 30 cases].
Arias Vallejo E; Diaz G; Moreno Arranz B; Lozano L
Minerva Med; 1969 Mar; 60(23):1057-62. PubMed ID: 5781333
[No Abstract] [Full Text] [Related]
11. [Therapeutic value of the combination of a corticosteroid (prednisone) with a gastroprotective substance (xylamide)].
Abbona C; Marugo M; Berretti A
Minerva Med; 1972 Sep; 63(60):3258-65. PubMed ID: 4559865
[No Abstract] [Full Text] [Related]
12. Effect of secretin and cholecystokinin on gastric emptying and gastric secretion in man.
Chey WY; Hitanant S; Hendricks J; Lorber SH
Gastroenterology; 1970 Jun; 58(6):820-7. PubMed ID: 5423893
[No Abstract] [Full Text] [Related]
13. Pharmacological studies on an antigastrin and antiulcer agent, SC-15396.
Bianchi RG; Cook DL
Fed Proc; 1968; 27(6):1331-6. PubMed ID: 5725225
[No Abstract] [Full Text] [Related]
14. [Therapeutic trial with a new anti-gastrin agent combined with a spasmolytic].
Malafaia O
Rev Bras Med; 1972 Mar; 29(3):148-50. PubMed ID: 5033158
[No Abstract] [Full Text] [Related]
15. [Pharmacology and experimental toxicology of a new non-anticholinergic product with antisecretory and gastroprotective activity (CR 242, xylamide-Milid)].
Rovati AL; Casula PL; Da Re G
Minerva Med; 1967 Oct; 58(86):3656-70. PubMed ID: 6061059
[No Abstract] [Full Text] [Related]
16. [Glucagon in the treatment of acute pancreatitis. A new therapeutic principle?].
Schmidt HA
Internist (Berl); 1972 Nov; 13(11):461-2. PubMed ID: 4564791
[No Abstract] [Full Text] [Related]
17. [Preliminary studies of the effects of xylamide on gastric secretion induced with caerulein].
Mantovani P; Piccinin GL; Romano A
Boll Soc Ital Biol Sper; 1970 Mar; 46(6):279-81. PubMed ID: 5458653
[No Abstract] [Full Text] [Related]
18. Gastric secretion in patients with chronic pancreatitis and in chronic alcoholics.
Chey WY; Kusakcioglu O; Dinoso V; Lorber SH
Arch Intern Med; 1968 Nov; 122(5):399-403. PubMed ID: 5687926
[No Abstract] [Full Text] [Related]
19. [Clinical trials of a pharmacological perparation in the therapy of ulcerous gastroduodenitis].
Linati E
Minerva Med; 1969 Mar; 60(23):1038-43. PubMed ID: 5781330
[No Abstract] [Full Text] [Related]
20. [Action of xylamide, CR 242, on gastric secretion of dogs after hypersecretory stimuli].
Danhof IA
Minerva Med; 1967 Oct; 58(86):3670-7. PubMed ID: 6061060
[No Abstract] [Full Text] [Related]
[Next] [New Search]
